Featuring Juan-Pablo Mas of Action Potential VC

Juan-Pablo is a partner at Action Potential Venture Captial in Scotts Valley, CA. He represents APVC on the Boards of Cala Health, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, SetPoint Medical, Onc.ai and previously CVRx (NASDAQ: CVRX). He was a founding team member and investor at Lightstone Ventures, and an investor at Morgenthaler Ventures, where he was a Board observer at Ardian (acq. by Medtronic), Twelve (acq. by Medtronic), Nuvaira, Cabochon Aesthetics (acq. by Ulthera/Merz), and Miramar Labs (acq. by Sientra).

Prior to investing, Juan-Pablo led efforts in R&D and Strategy in Medtronic’s CardioVascular Division, where he developed implantable heart valves, neuro-interventional catheters, vascular closure devices and evaluated various forms of medical imaging for advanced medical procedures.  He was named “Medtronic Inventor of The Year”. Subsequently, he was on the Global Brand Strategy team at Eli Lilly within the Cardiovascular Pharma business.

Juan-Pablo earned an MBA and an M.S. in Electrical Engineering from Stanford University, and a B.S. in Electrical Engineering from the University of Massachusetts. He was a GEM Fellow (https://www.gemfellowship.org/) in graduate school.  Today, he serves on Stanford’s Neuroscience Institute Oversight Committee, the Advisory Board for UCSF’s Rosenman Institute, the Investor Advisory Committee of AdvaMed, and is a founding Board Member of SomosVC which is dedicated to increasing the representation and advancement of Latino and Latina VCs across industry verticals.  He played Division I men’s lacrosse at the University of Massachusetts, serves on the Board of USA Lacrosse since 2023, and is originally from Puerto Rico.